Computation in the service of therapeutics.

From disease biology to experimentally testable leads. Six themes, one toolkit, and a signature discovery pipeline.

Shortening the distance between a biological question and a molecule worth testing.

Across infectious and non-infectious diseases, I integrate bioinformatics, cheminformatics, omics analysis, molecular modelling, and artificial intelligence to identify and prioritise therapeutic targets, then to find and refine the bioactive molecules most likely to act on them. The work spans AI and machine learning for predictive modelling and QSAR; structure- and ligand-based discovery; immunoinformatics and reverse vaccinology; omics and network pharmacology; natural-product and peptide therapeutics; and protein engineering.

The aim throughout is practical: computationally informed solutions that are reproducible, interpretable, and ready to hand to experimental collaborators.

Six lines of computational enquiry

AI & Machine Learning in Biomedicine

Predictive modelling, QSAR, and data-driven therapeutic discovery.

Drug Discovery & Molecular Modelling

Docking, pharmacophores, virtual screening, dynamics, ADME.

Immunoinformatics & Reverse Vaccinology

Epitope selection and multi-epitope vaccine design.

Omics, Networks & Biomarkers

Transcriptomics, proteomics, and network pharmacology.

Natural Products, Peptides & Phytotherapeutics

Bioactive peptides and phytochemical therapeutics.

Protein Engineering & Functional Annotation

Structure/function prediction and enzyme stability.

From biological target to testable lead molecule.

A five-stage computational pipeline sits at the centre of every project, carrying a disease question from its molecular origin to candidates ready for the bench.

01

Target Identification

Define and prioritise therapeutic targets.

02

Virtual Screening

Screen large libraries to find promising hits.

03

Lead Optimisation

Improve potency, selectivity, and drug-likeness.

04

ADMET Prediction

Evaluate safety, PK/PD, and developability.

05

Drug Candidates

Advance the best candidates to the bench.

Methods used across projects

Target discovery and prioritisation from biological and disease data

Protein structure modelling and binding-site analysis

Molecular docking, virtual screening and drug repurposing

Ligand-based design, pharmacophore modelling and QSAR

ADMET profiling and molecular dynamics simulations

Natural-product research and AI-assisted lead optimisation

Cancer Viral & Bacterial Infections Neurodegeneration Metabolic Disorders Inflammatory Disease Antimicrobial Resistance

Featured projects

Each project is summarised the same way: question, methods, contribution, output. Full write-ups are added as work is published.

Anti-infective target discovery

Write-up in preparation.

Reverse vaccinology

Write-up in preparation.

AI-assisted lead optimisation

Write-up in preparation.

Doctoral scholars, master's students & alumni

Enquire about joining →
9 PhD scholars 4 awarded · 5 ongoing
Master's students Dissertation projects across themes
Alumni & collaborators Listed with consent

Where enquiries are welcome

Disease areas

Cancer & non-infectious disease Viral & bacterial infections Antimicrobial resistance Neurodegeneration & metabolic disease

Technologies

Molecular modelling & docking Immunoinformatics & vaccine design Omics & network pharmacology AI/ML for drug discovery

Formats

Joint research projects Co-supervision of students Method development Data analysis partnerships